Pulp therapy for management of deep caries in primary molar teeth

Not Applicable

• Conditions: Management of deep caries in children; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12609000658213
• Lead Sponsor: Dr Sonali Mistry

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-08-04
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

Healthy children attending Logan-Beaudesert Area Oral Health Program for routine dental treatment, and requiring management of deep caries.

Exclusion Criteria

All subjects recruited in the study will be systemically healthy although they may have decayed teeth.

So the key exclusion criteria is: Unhealthy children, for example, children with chronic illness such as cancer, and children outside the age range of 2-8years

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Success rates of the pulp therapy.<br><br>This will be assessed by clinical and radiographic assessment where the absence of signs of infection and/or inflammation will be looked for. These include pain, redness, swelling, abscess, non-physiologic mobility and pathologic radiolucency on radiographs.<br><br>Moreover, a subjective interrogation to the parent or guardian of the child will be carried out to determine any signs and/or symptoms experienced by the patient.<br><br>Moreover, any other signs and symptoms that may not be accounted for, and are experienced by the child due to pulp therapy will also be noted.[2 years from intervention]

Secondary Outcome Measures

Name	Time	Method
Signs and Symptoms<br><br>For example, signs of infection and/or inflammation such as pain, redness, swelling, abscess and non-physiologic mobility[When the patient experiences symptoms or signs of concerns in the 2 year period following intervention.];Clinical and radiographic assessment[At baseline, 3 months and every 6 months after intervention for 2 years.]